Use of Glucagon-like peptide 2 (GLP-2) analogs in inflammatory bowel disease

• 主要な著者: Dobromiła Osuch (著者), Piotr Zatyka (著者), Adam Słomczyński (著者), Agata Pawłowska (著者), Michal Rabenda (著者), Piotr Janik (著者), Dominika Opala (著者)
• フォーマット: 図書
• 出版事項: Nicolaus Copernicus University in Toruń, 2024-08-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Introduction: Inflammatory bowel disease (IBD) is a chronic condition that involves long-term treatment and chronic idiopathic inflammation within the gastrointestinal tract. The predominant forms of IBD are: Crohn's disease and ulcerative colitis. These diseases cause significant physical as w...